{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:49:05Z","timestamp":1791413345342,"version":"4.3.3"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.diabres.2025.112334","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:56:35Z","timestamp":1750359395000},"page":"112334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes"],"prefix":"10.1016","volume":"226","author":[{"given":"Maria","family":"Claro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6888-0396","authenticated-orcid":false,"given":"Clara","family":"Vi\u00f1als","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marga","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Perea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7536-4824","authenticated-orcid":false,"given":"Montserrat","family":"Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonet","family":"Ser\u00e9s-Noriega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5903-430X","authenticated-orcid":false,"given":"Jes\u00fas","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8760-3370","authenticated-orcid":false,"given":"Irene","family":"Vinagre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0696-2529","authenticated-orcid":false,"given":"Alex","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7140-4297","authenticated-orcid":false,"given":"Camila","family":"Milad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisse","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8618-0760","authenticated-orcid":false,"given":"Clara","family":"Sol\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6329-5059","authenticated-orcid":false,"given":"Enric","family":"Esmatjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Conget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9237-0903","authenticated-orcid":false,"given":"Antonio J.","family":"Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.diabres.2025.112334_b0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.diabres.2025.112334_b0010","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.diabres.2025.112334_b0015","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.diabres.2025.112334_b0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrendo.2017.173","article-title":"Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus","volume":"14","author":"Targher","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"10.1016\/j.diabres.2025.112334_b0025","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa575","article-title":"Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"105","author":"De Vries","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2025.112334_b0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.diabres.2025.112334_b0035","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/j.gastro.2016.03.005","article-title":"Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.diabres.2025.112334_b0040","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/eurheartj\/ehr453","article-title":"Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?","volume":"33","author":"Bhatia","year":"2012","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.diabres.2025.112334_b0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.diabres.2025.112334_b0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.diabres.2025.112334_b0055","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"issue":"14","key":"10.1016\/j.diabres.2025.112334_b0060","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.7150\/ijms.62010","article-title":"Association of hepatic steatosis index and fatty liver index with carotid atherosclerosis in type 2 diabetes","volume":"18","author":"Wang","year":"2021","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.diabres.2025.112334_b0065","article-title":"The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study","volume":"21(1):53","author":"Park","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2025.112334_b0070","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/PL00002934","article-title":"Mortality and causes of death in the WHO multinational study of vascular disease in diabetes","volume":"Sep:44 Suppl 2","author":"Morrish","year":"2001","journal-title":"Diabetologia"},{"issue":"17","key":"10.1016\/j.diabres.2025.112334_b0075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030739","article-title":"Carotid Plaque score for Stroke and Cardiovascular Risk Prediction in a Middle-Aged Cohort from the General Population","volume":"12","author":"Ihle-Hansen","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.diabres.2025.112334_b0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1012592","article-title":"Carotid-wall intima-media thickness and cardiovascular events","volume":"365","author":"Syed","year":"2011","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.diabres.2025.112334_b0085","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/1753-0407.12539","article-title":"A low prevalence of non alcoholic fatty liver disease in patients with type 1 diabetes is associated to decreased subclinical cardiovascular disease steatosis, type 1 diabetes and coronariopathy","volume":"9","author":"Serra-planas","year":"2017","journal-title":"J Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2025.112334_b0090","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jhep.2010.04.030","article-title":"Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes","volume":"53","author":"Targher","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2025.112334_b0095","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijcard.2016.10.040","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes","volume":"225","author":"Mantovani","year":"2016","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112334_b0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02171-9","article-title":"Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study","volume":"23","author":"Garofolo","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.diabres.2025.112334_b0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12933-023-01945-x","article-title":"Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus","volume":"22","author":"Mantovani","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.diabres.2025.112334_b0110","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00592-022-01959-z","article-title":"Carotid ultrasonography as a strategy to optimize cardiovascular risk management in type 1 diabetes: a cohort study","volume":"59","author":"Boswell","year":"2022","journal-title":"Acta Diabetol"},{"issue":"10","key":"10.1016\/j.diabres.2025.112334_b0115","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.2337\/dc22-0118","article-title":"Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better than use of ESC\/EASD-2019 in Adult Subjects with Type 1 Diabetes at High Risk","volume":"45","author":"Ser\u00e9s-Noriega","year":"2022","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2025.112334_b0120","doi-asserted-by":"crossref","first-page":"e1759","DOI":"10.1210\/clinem\/dgad755","article-title":"Impact of preeclampsia and parity on sex-based discrepancies in subclinical carotid atherosclerosis in type 1 diabetes","volume":"109","author":"Perea","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.diabres.2025.112334_b0125","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s13300-024-01616-4","article-title":"Evaluation of Cardiovascular Risk in people with Type 1 Diabetes: a Comprehensive and specific Proposed Practical Approach","volume":"15","author":"Vi\u00f1als","year":"2024","journal-title":"Diabetes Therapy"},{"issue":"4","key":"10.1016\/j.diabres.2025.112334_b0130","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/diacare.18.4.517","article-title":"Reduced Awareness of Hypoglycemia in adults with IPPM a prospective Study of Hypoglycemic Frequency and Associated Symptoms","volume":"18","author":"Clarke","year":"1995","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.diabres.2025.112334_b0135","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCULATIONAHA.115.018844","article-title":"Prediction of first cardiovascular disease event in type 1 diabetes mellitus the steno type 1 risk engine","volume":"133","author":"Vistisen","year":"2016","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.diabres.2025.112334_b0140","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"9","key":"10.1016\/j.diabres.2025.112334_b0145","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s40618-021-01501-y","article-title":"Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. a multicenter retrospective study in italian specialist care","volume":"44","author":"Morieri","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.diabres.2025.112334_b0150","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jgh.13814","article-title":"Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes","volume":"33","author":"Svikl\u0101ne","year":"2018","journal-title":"Journal of Gastroenterology and Hepatology (Australia)"},{"issue":"40","key":"10.1016\/j.diabres.2025.112334_b0155","doi-asserted-by":"crossref","first-page":"e1682","DOI":"10.1097\/MD.0000000000001682","article-title":"Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly chinese","volume":"94","author":"Huang","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.diabres.2025.112334_b0160","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.dld.2021.04.029","article-title":"Non-alcoholic fatty liver disease in adults 2021: a clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)","volume":"54","author":"Marchesini","year":"2022","journal-title":"Dig Liver Dis"},{"issue":"7","key":"10.1016\/j.diabres.2025.112334_b0165","doi-asserted-by":"crossref","first-page":"e3323","DOI":"10.1002\/dmrr.3323","article-title":"Insulin resistance is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes","volume":"36","author":"Pan\u00e9","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"4","key":"10.1016\/j.diabres.2025.112334_b0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","article-title":"Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011)","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc Dis"},{"issue":"10","key":"10.1016\/j.diabres.2025.112334_b0175","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2337\/dci21-0035","article-title":"Hemoglobin a1c\u2014using epidemiology to guide medical practice: kelly west award lecture 2020","volume":"44","author":"Selvin","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112334_b0180","doi-asserted-by":"crossref","unstructured":"Michelle D Lundholm, James Bena, Keren Zhou, Yumiko Tsushima, Sangeeta R Kashyap. Prevalence and clinical determinants of non-alcoholic fatty liver disease by liver scores in adults with type 1 diabetes. J Diabetes Complications. 2023. Feb;37(2):108405. doi: 10.1016\/j.jdiacomp.2023.108405.","DOI":"10.1016\/j.jdiacomp.2023.108405"},{"issue":"9","key":"10.1016\/j.diabres.2025.112334_b0185","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1007\/s40618-024-02333-2","article-title":"Blood glucose control and metabolic dysfunction-associated steatotic liver disease in people with type 1 diabetes","volume":"47","author":"Della Pepa","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.diabres.2025.112334_b0190","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00330-011-2326-9","article-title":"Prediction for steatosis in type-2 diabetes: Clinico-biological markers versus 1H-MR spectroscopy","volume":"22","author":"Guiu","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diabres.2025.112334_b0195","doi-asserted-by":"crossref","unstructured":"Hong S hyeon, Sung YA, Hong YS, Song DK, Jung H, Jeong K, Chung H, Lee H. Non-alcoholic fatty liver disease is associated with hyperandrogenism in women with polycystic ovary syndrome. Sci Rep. 2023;13(1):13397. doi:10.1038\/s41598-023-39428-4.","DOI":"10.1038\/s41598-023-39428-4"},{"key":"10.1016\/j.diabres.2025.112334_b0200","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"10.1016\/j.diabres.2025.112334_b0205","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(21)00246-1","article-title":"Obesity in people living with type 1 diabetes","volume":"9","author":"Van der Schueren","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.diabres.2025.112334_b0210","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2337\/dc18-1446","article-title":"BMI, mortality, and cardiovascular outcomes in type 1 diabetes: Findings against an obesity paradox","volume":"42","author":"Edqvist","year":"2019","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2025.112334_b0215","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/aje\/kwx386","article-title":"Hemoglobin a 1c Level and Cardiovascular Disease Incidence in Persons with Type 1 Diabetes: an Application of Joint Modeling of Longitudinal and Time-to-Event Data in the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"187","author":"Miller","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.diabres.2025.112334_b0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41366-023-01429-8","article-title":"The emergence of obesity in type 1 diabetes","volume":"48","author":"Kueh","year":"2024","journal-title":"Int J Obes"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725003481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725003481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T21:06:17Z","timestamp":1753909577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725003481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":44,"alternative-id":["S0168822725003481"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112334","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic steatosis with significant fibrosis is associated with preclinical carotid atherosclerosis in patients with type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112334"}}